ESMO Targeted Anticancer Therapies Congress 2023 took place on 6-8 March 2023 in Paris, France

ESMO TAT, known as “The Home of Phase I in Oncology”, is the leading congress focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development.

This congress was dedicated to improving the conduct of early anti-cancer clinical trials, bringing together those who are developing the most promising new cancer drugs and unveiling exciting new data.

With a record-breaking number of abstracts submitted, this edition offered a unique opportunity for stakeholders from academia and industry to discuss with clinicians, researchers, and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.